Enlivex Therapeutics Ltd. (ENLV)
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.
Address
37 DEREH MENACHEM BEGIN ST.
TEL AVIV, L3 6522042
Founded
2012
Number of Employees
49
Website
http://www.enlivex.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)